[Value of associated estro-progestinic therapy in disorders of the female climacteric and of the post-menopausal period].
D000328:Adult; D000368:Aged; D004402:Dysautonomia, Familial / Q000188:drug therapy; D004967:Estrogens / Q000627:therapeutic use*; D004997:Ethinyl Estradiol / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008525:Medroxyprogesterone / Q000627:therapeutic use*; D008593:Menopause / Q000187:drug effects*; D008875:Middle Aged; D011372:Progestins / Q000627:therapeutic use*; D011539:Pruritus Vulvae / Q000188:drug therapy; D014596:Uterine Prolapse / Q000150:complications; D007724:Vulvar Lichen Sclerosus / Q000188:drug therapy; D014848:Vulvovaginitis / Q000188:drug therapy
D004967:Estrogens; D011372:Progestins; D004997:Ethinyl Estradiol; D008525:Medroxyprogesterone
Utilità di una terapia estro-progestinica associata, nei disturbi del climaterio femminile e della post-menopausa.